Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. AVAH
AVAH logo

AVAH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
7.135
Open
7.130
VWAP
7.03
Vol
850.56K
Mkt Cap
1.47B
Low
6.935
Amount
5.98M
EV/EBITDA(TTM)
11.54
Total Shares
208.91M
EV
2.83B
EV/OCF(TTM)
31.58
P/S(TTM)
0.65
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. It also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.
Show More

Events Timeline

(ET)
2026-01-14
16:20:00
Major Averages Decline for Second Straight Day
select
2026-01-14
12:10:00
Major Averages Decline for Second Straight Day as Investor Sentiment Softens
select
2026-01-14
08:40:00
Sees FY26 Adjusted EBITDA Between $318 Million and $322 Million
select

News

Newsfilter
9.5
02-26Newsfilter
Aveanna Healthcare to Release Q4 2026 Earnings Results
  • Earnings Release Schedule: Aveanna Healthcare is set to announce its fourth quarter and full year results on March 19, 2026, before market open, which is expected to provide investors with critical financial performance data to assess the company's operational status.
  • Conference Call Details: The company will host a conference call at 10:00 a.m. (Eastern Time) on the same day, allowing investors to participate by dialing 1-877-407-0789, with international callers using 1-201-689-8562, ensuring global investor engagement in the discussion.
  • Replay Service: A replay of the conference call will be available three hours after its conclusion, accessible by dialing 1-844-512-2921 (international callers can use 1-412-317-6671), with the replay service lasting until March 26, 2026, facilitating information access for those unable to attend live.
  • Online Webcast: Investors can also listen to a simultaneous webcast of the conference call via the Investor Relations section of the company's website, with the online replay available for one week post-call, further enhancing information accessibility and transparency.
Yahoo Finance
4.5
01-14Yahoo Finance
Health Care Stocks Rise, NYSE Health Care Index Shows Strong Performance
  • Healthcare Stocks Rise: Late Wednesday afternoon, healthcare stocks broadly increased, reflecting growing market confidence in the healthcare sector, which may attract more investor attention to this field.
  • NYSE Health Care Index Performance: The rise in the NYSE Health Care Index indicates a healthy overall condition for the industry, potentially driving up stock prices of related companies and enhancing investor returns.
  • Market Trends: The positive performance of the healthcare sector may be linked to recent policy changes and increasing market demand, demonstrating sustained investor interest in healthcare services and products.
  • Investor Confidence: The rise in healthcare stocks could bolster investor confidence in the broader market, especially amid increasing economic uncertainty, as the healthcare sector is viewed as a relatively safe investment choice.
seekingalpha
7.0
01-14seekingalpha
Aveanna Healthcare (AVAH) Raises 2025 Revenue Guidance to $2.425B-$2.445B, Exceeding Consensus
  • Revenue Guidance Increase: Aveanna Healthcare raised its 2025 revenue guidance to $2.425B-$2.445B, surpassing the previous estimate of $2.375B from November, indicating strong growth potential in the home healthcare sector.
  • EBITDA Guidance Boost: The company increased its adjusted EBITDA forecast to nearly $318M-$322M, up from over $300M previously, reflecting improved operational efficiency and enhanced profitability.
  • 2026 Outlook: Aveanna expects to generate $2.54B-$2.56B in revenue for 2026, slightly below the consensus of $2.57B, yet still indicating a sustained growth trajectory and competitive strength in the market.
  • Investor Conference Preview: The financial guidance update coincides with the company's presentation at the J.P. Morgan Healthcare Conference in San Francisco, which is expected to attract investor interest and bolster market confidence.
Newsfilter
7.0
01-14Newsfilter
Aveanna Healthcare Updates 2025 Guidance, Forecasts Revenue of $2.445 Billion
  • 2025 Revenue Forecast: Aveanna Healthcare anticipates revenue for 2025 to reach approximately $2.445 billion, an increase from previous estimates, indicating sustained growth potential in the high-cost patient care sector.
  • Net Income Outlook: The expected net income for 2025 is projected to be between $181 million and $220 million, reflecting the company's profitability and financial stability in the complex healthcare market.
  • Initial 2026 Guidance: The company forecasts revenue for 2026 to be between $2.54 billion and $2.56 billion, demonstrating confidence in future growth despite not providing net income guidance due to market volatility.
  • Adjusted EBITDA Expectations: The adjusted EBITDA for 2025 is expected to range from $318 million to $322 million, indicating ongoing efforts to enhance operational efficiency and cost control will continue to drive financial performance.
Fool
5.0
01-08Fool
Aveanna Healthcare's CCO Sells 36,015 Shares for $292,488 Amid Turnaround
  • Insider Transaction: Aveanna Healthcare's Chief Compliance Officer sold 36,015 shares between December 30 and January 2 at a weighted average price of $8.12, totaling $292,488, marking the largest single open-market sale in the past year.
  • Ownership Reduction: This transaction reduced Cunningham's direct holdings by approximately 11%, from 329,369 shares to 293,354 shares, highlighting the increased significance of each sale due to his diminished stake.
  • Business Turnaround: Aveanna reported a 22.2% year-over-year revenue increase in Q3 to $621.9 million, with adjusted EBITDA soaring 67.5% to $80.1 million, prompting management to raise full-year revenue guidance to over $2.375 billion, indicating a significant business turnaround.
  • Market Implications: While Cunningham's stock sale may attract attention, investors should focus on Aveanna's sustained margin expansion and cash generation, which are crucial for the company's future growth prospects.
NASDAQ.COM
5.0
01-08NASDAQ.COM
Aveanna Healthcare Executive Sells 36,015 Shares for $292,488
  • Insider Selling: Patrick A. Cunningham, the Chief Compliance Officer of Aveanna Healthcare, sold 36,015 shares between December 30 and January 2 for a total of $292,488, representing 10.93% of his direct holdings, reducing his ownership to 293,354 shares, indicating a strategic adjustment in executive shareholding.
  • Tax Obligation Impact: The sale was executed to satisfy tax obligations related to vested equity awards rather than discretionary selling, suggesting that executives remain optimistic about the company's long-term prospects.
  • Performance Rebound: Aveanna Healthcare reported a 22.2% year-over-year revenue increase to $621.9 million in Q3, with adjusted EBITDA soaring 67.5% to $80.1 million, prompting management to raise full-year revenue guidance to over $2.375 billion, indicating a significant business turnaround.
  • Strong Market Performance: Over the past year, Aveanna's stock has surged approximately 99%, significantly outperforming the S&P 500's 17% gain, reflecting strong market confidence in the company's ongoing operational improvements and future growth potential.
Wall Street analysts forecast AVAH stock price to rise
5 Analyst Rating
Wall Street analysts forecast AVAH stock price to rise
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
10.00
Averages
10.75
High
11.00
Current: 0.000
sliders
Low
10.00
Averages
10.75
High
11.00
BMO Capital
Outperform
initiated
$11
AI Analysis
2025-11-12
Reason
BMO Capital
Price Target
$11
AI Analysis
2025-11-12
initiated
Outperform
Reason
BMO Capital initiated coverage of Aveanna with an Outperform rating and $11 price target. Shares are up about 130% since early August on strong Q2 and Q3 results fueled by state reimbursement increases, preferred payer expansion, and disciplined cost control, which also lowered leverage, the analyst tells investors in a research note. While future Medicaid rate hikes may be limited, ongoing payer conversions, cost discipline, and potential M&A underpin expectations for 10+ long-term EBITDA growth, the firm says.
UBS
AJ Rice
Neutral
maintain
$9
2025-11-07
Reason
UBS
AJ Rice
Price Target
$9
2025-11-07
maintain
Neutral
Reason
UBS analyst AJ Rice raised the firm's price target on Aveanna to $9.50 from $9 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AVAH
Unlock Now

Valuation Metrics

The current forward P/E ratio for Aveanna Healthcare Holdings Inc (AVAH.O) is 14.66, compared to its 5-year average forward P/E of 39.58. For a more detailed relative valuation and DCF analysis to assess Aveanna Healthcare Holdings Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
39.58
Current PE
14.66
Overvalued PE
145.45
Undervalued PE
-66.29

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
12.43
Current EV/EBITDA
9.87
Overvalued EV/EBITDA
14.15
Undervalued EV/EBITDA
10.71

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.42
Current PS
0.67
Overvalued PS
0.71
Undervalued PS
0.13

Financials

AI Analysis
Annual
Quarterly

Whales Holding AVAH

J
Jaunty Global Limited
Holding
AVAH
-9.62%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Aveanna Healthcare Holdings Inc (AVAH) stock price today?

The current price of AVAH is 7.03 USD — it has decreased -2.5

What is Aveanna Healthcare Holdings Inc (AVAH)'s business?

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. It also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.

What is the price predicton of AVAH Stock?

Wall Street analysts forecast AVAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVAH is10.75 USD with a low forecast of 10.00 USD and a high forecast of 11.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Aveanna Healthcare Holdings Inc (AVAH)'s revenue for the last quarter?

Aveanna Healthcare Holdings Inc revenue for the last quarter amounts to 621.94M USD, increased 22.18

What is Aveanna Healthcare Holdings Inc (AVAH)'s earnings per share (EPS) for the last quarter?

Aveanna Healthcare Holdings Inc. EPS for the last quarter amounts to 0.06 USD, decreased -127.27

How many employees does Aveanna Healthcare Holdings Inc (AVAH). have?

Aveanna Healthcare Holdings Inc (AVAH) has 3500 emplpoyees as of March 11 2026.

What is Aveanna Healthcare Holdings Inc (AVAH) market cap?

Today AVAH has the market capitalization of 1.47B USD.